The company moves ahead on its leukemia treatment, after encouraging study results.
Based on performance, cost and risk, these rank as favorites for large-cap investing.
The S&P 500 breaks above 1,600 and the Dow eclipses 15,000 after the government reports stronger-than-expected jobs figures for April.
A biotech's focus on developing a drug for the chronic disease gets a boost from new, positive data.
Unlike biotechs, many of these companies are pouring money into share buybacks -- instead of their long-term pipelines.
US markets are set for a higher open on ECB rate cut, upbeat earnings reports.
The only explanation for recent stock action is market players following others blindly. The bulls just have to hope analysts don't think this is National Lemming Week.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.